Regeneron and AstraZeneca to Research, Develop and Commercialize New Small Molecule Medicines for Obesity

Tuesday, July 27, 2021 1 min read

Key Takeaway: Regeneron and AstraZeneca to Research, Develop and Commercialize New Small Molecule Medicines for Obesity

Full Press Release Details

Regeneron and AstraZeneca to Research, Develop and Commercialize New Small Molecule Medicines for Obesity.